Blacksmith Medicines

Developer of therapeutics for immuno-oncology and inflammatory diseases

placeSan Diego, California, United States calendar_todayFounded 2019 groups11 employees language blacksmithmedicines.com

Innovation

12 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 392 times.

YearFilings
20211
20221
20237
20247
20257
20262

Social engagement

Social engagement: 675 social following, 3 posts in the last 12 months — top 10% of its industry.

Investor mix

6 investors on record; lead investors include Lilly.

Investor typeCountShare
Venture capital233%
Other / undisclosed467%

Recent activity

24 Nov 2025
Milestone
regulatory
13 Oct 2025
Recognition
1 Aug 2025
Event
Keynote Talk at the International Conference on Biological Inorganic Chemistry
Coming soon